Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics

The 60 kDa heat shock protein (Hsp60) is classically known as a mitochondrial chaperonin protein working together with co-chaperonin 10 kDa heat shock protein (Hsp10). This chaperonin complex is essential for folding proteins newly imported into mitochondria. However, Hsp60, and/or Hsp10 have also b...

Full description

Bibliographic Details
Main Authors: Qianli Meng, Bingbing X. Li, Xiangshu Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmolb.2018.00035/full
_version_ 1818536266915905536
author Qianli Meng
Bingbing X. Li
Xiangshu Xiao
author_facet Qianli Meng
Bingbing X. Li
Xiangshu Xiao
author_sort Qianli Meng
collection DOAJ
description The 60 kDa heat shock protein (Hsp60) is classically known as a mitochondrial chaperonin protein working together with co-chaperonin 10 kDa heat shock protein (Hsp10). This chaperonin complex is essential for folding proteins newly imported into mitochondria. However, Hsp60, and/or Hsp10 have also been shown to reside in other subcellular compartments including extracellular space, cytosol, and nucleus. The proteins in these extra-mitochondrial compartments may possess a wide range of functions dependent or independent of its chaperoning activity. But the mechanistic details remain unknown. Mutations in Hsp60 gene have been shown to be associated with neurodegenerative disorders. Abnormality in expression level and/or subcellular localization have also been detected from different diseased tissues including inflammatory diseases and various cancers. Therefore, there is a strong interest in developing small molecule modulators of Hsp60. Most of the reported inhibitors were discovered through various chemoproteomics strategies. In this review, we will describe the recent progress in this area with reported inhibitors from both natural products and synthetic compounds. The former includes mizoribine, epolactaene, myrtucommulone, stephacidin B, and avrainvillamide while the latter includes o-carboranylphenoxyacetanilides and gold (III) porphyrins. The potencies of the known inhibitors range from low micromolar to millimolar concentrations. The potential applications of these inhibitors include anti-cancer, anti-inflammatory diseases, and anti-autoimmune diseases.
first_indexed 2024-12-11T18:35:45Z
format Article
id doaj.art-e8b69218aced4cb1846cedb15320f93d
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-12-11T18:35:45Z
publishDate 2018-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-e8b69218aced4cb1846cedb15320f93d2022-12-22T00:54:46ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2018-04-01510.3389/fmolb.2018.00035347365Toward Developing Chemical Modulators of Hsp60 as Potential TherapeuticsQianli MengBingbing X. LiXiangshu XiaoThe 60 kDa heat shock protein (Hsp60) is classically known as a mitochondrial chaperonin protein working together with co-chaperonin 10 kDa heat shock protein (Hsp10). This chaperonin complex is essential for folding proteins newly imported into mitochondria. However, Hsp60, and/or Hsp10 have also been shown to reside in other subcellular compartments including extracellular space, cytosol, and nucleus. The proteins in these extra-mitochondrial compartments may possess a wide range of functions dependent or independent of its chaperoning activity. But the mechanistic details remain unknown. Mutations in Hsp60 gene have been shown to be associated with neurodegenerative disorders. Abnormality in expression level and/or subcellular localization have also been detected from different diseased tissues including inflammatory diseases and various cancers. Therefore, there is a strong interest in developing small molecule modulators of Hsp60. Most of the reported inhibitors were discovered through various chemoproteomics strategies. In this review, we will describe the recent progress in this area with reported inhibitors from both natural products and synthetic compounds. The former includes mizoribine, epolactaene, myrtucommulone, stephacidin B, and avrainvillamide while the latter includes o-carboranylphenoxyacetanilides and gold (III) porphyrins. The potencies of the known inhibitors range from low micromolar to millimolar concentrations. The potential applications of these inhibitors include anti-cancer, anti-inflammatory diseases, and anti-autoimmune diseases.http://journal.frontiersin.org/article/10.3389/fmolb.2018.00035/fullautoimmunecancerchaperoneGroELGroESHsp60
spellingShingle Qianli Meng
Bingbing X. Li
Xiangshu Xiao
Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics
Frontiers in Molecular Biosciences
autoimmune
cancer
chaperone
GroEL
GroES
Hsp60
title Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics
title_full Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics
title_fullStr Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics
title_full_unstemmed Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics
title_short Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics
title_sort toward developing chemical modulators of hsp60 as potential therapeutics
topic autoimmune
cancer
chaperone
GroEL
GroES
Hsp60
url http://journal.frontiersin.org/article/10.3389/fmolb.2018.00035/full
work_keys_str_mv AT qianlimeng towarddevelopingchemicalmodulatorsofhsp60aspotentialtherapeutics
AT bingbingxli towarddevelopingchemicalmodulatorsofhsp60aspotentialtherapeutics
AT xiangshuxiao towarddevelopingchemicalmodulatorsofhsp60aspotentialtherapeutics